MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer
Han Li(Shanghai First Maternity and Infant Hospital), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Wenhao Tan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongyao Pu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dan Shu(The Ohio State University), Zhenrong Tang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Meiying Shen, Wenjie Zhang(Shanghai Jiao Tong University), Aishun Jin, Kang Li(Harbin Engineering University), Zhaofu Tan(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 10
Related Papers
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions
|Cancer Immunology Immunotherapy|2018|286
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2020|175
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
|Molecular Therapy|2017|147